Literature DB >> 2310768

Cellular cholesterol metabolism in mitogen-stimulated lymphocytes--requirement for de novo synthesis.

D Owens1, P Collins, A Johnson, G Tomkin.   

Abstract

The relationship between cholesterol synthesis and uptake in proliferating lymphocytes has been examined. [14C]Acetate incorporation into lymphocytes cultured under lipoprotein-deficient conditions increased initially in response to mitogen, decreased after 24 h, and increased rapidly between 72 and 96 h. Addition of LDL (10 micrograms/ml) to the culture during the 'trough' period caused [14C]acetate incorporation to return rapidly to baseline, while at peak periods LDL suppression of cholesterol synthesis was minimal. Lymphocytes cultured in the presence of the HMG-CoA reductase inhibitor, mevinolin, exhibited a time-dependent increase in their capacity to incorporate [14C]acetate into cholesterol, evident when mevinolin was removed by washing prior to assay. PHA enhanced 125I-labelled LDL receptor-mediated binding by lymphocytes cultured in lipoprotein-deficient medium over a 4 day period and mevinolin augmented the effect. [3H]Thymidine incorporation into mitogen-stimulated lipoprotein-deficient cultures was inhibited up to 75% by mevinolin (1 mumol/l). LDL (2.5-10 micrograms/ml) substantially reversed this inhibition in 72 h cultures, but only partially overcame inhibition in cells cultured for 96 h. Results suggest that endogenous cholesterol synthesis may be obligatory for lymphocyte proliferation after the initial round of cell division.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310768     DOI: 10.1016/0167-4889(90)90185-g

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Quantitative assay for morphogenesis indicates the role of extracellular matrix components and G proteins.

Authors:  R J Klebe; T M Overfelt; V L Magnuson; B Steffensen; D L Chen; G Zardeneta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 2.  Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.

Authors:  A Lonardo; P Tarugi; G Ballarini; A Bagni
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Alterations in cellular cholesterol metabolism following administration of 6-hydroxydopamine to rabbits.

Authors:  N M O'Meara; R A Devery; D Owens; P B Collins; A H Johnson; G H Tomkin
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

4.  The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects.

Authors:  D Owens; S McBrinn; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Effects of lovastatin on natural killer cell function and other immunological parameters in man.

Authors:  R McPherson; C Tsoukas; M G Baines; A Vost; M R Melino; R V Zupkis; H F Pross
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

6.  Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Authors:  O Hernández-Perera; D Pérez-Sala; J Navarro-Antolín; R Sánchez-Pascuala; G Hernández; C Díaz; S Lamas
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

7.  Apolipoprotein B-100 XbaI gene polymorphism in gallbladder cancer.

Authors:  Mahendra Kumar Singh; Udai Bhan Pandey; Uday Chand Ghoshal; Itha Srivenu; Vinay Kumar Kapoor; Gourdas Choudhuri; Balraj Mittal
Journal:  Hum Genet       Date:  2003-11-14       Impact factor: 4.132

8.  Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells.

Authors:  Lindsay McCaw; Yonghong Shi; Guizhi Wang; You-Jun Li; David E Spaner
Journal:  EBioMedicine       Date:  2016-11-30       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.